Jiangsu Jiyuan Medical Technology Co., Ltd., founded in 2017, has been committed to the in‑depth R&D and extensive application of electronic endoscope technologies. It is a high‑tech enterprise specializing in the development and promotion of electronic endoscope technologies. Headquartered in CECEP Science and Technology Industrial Park, Taizhou City, Jiangsu Province, the Phase‑I project comprises two 1,318 m² GMP workshops, one 1,500 m² warehousing & logistics center and a 1,200 m² R&D building within the industrial park. Meanwhile, four wholly‑owned subsidiaries have been established in Beijing, Shenzhen, Hefei and Singapore, mainly responsible for R&D and global sales.

Guided by its vision of “Caring for women’s health and delivering integrated solutions for gynecological minimally‑invasive procedures”, Jiyuan Medical takes “Pioneering a new era of visual intrauterine outpatient / day‑case diagnosis and treatment” as its mission, and keeps pursuing minimally‑invasive, intelligent and outpatient‑oriented intrauterine diagnosis‑and‑treatment technologies. Jiyuan Medical firmly believes that through continuous technological innovation and service optimization, it can make greater contributions to women’s health worldwide.

Since its establishment, the company has consistently devoted itself to intensive R&D. A range of products including the endoscope image processor system, single‑use electronic hysteroscopes and supporting single‑use surgical instruments have been granted China NMPA certification, US FDA clearance, EU ISO 13485 certification and EU MDR certification. This enriches product supply for China’s domestic single‑use gynecological endoscope market and positions the company as one of the early enterprises that have obtained certifications from China, the United States and the European Union and realized mass production in the single‑use hysteroscope segment. At present, relevant products have been launched and sold in many countries and regions including China, the United States, India, Europe, Latin America, Southeast Asia, the Middle East and Africa. Supported by solid technical capabilities, the enterprise has been awarded more than 40 domestic and international patents, boasting strong market competitiveness in its niche sector.